The maintenance dose The maintenance dose is the ongoing dose of a medication after the dose adjustment or titration phase
GLP-1 plays a role in appetite regulation, digestion, and blood sugar balance
The genetic test also evaluates FTO (rs9939609) and MC4R (rs17782313) variants linked to metabolic regulation and appetite signaling
In addition, it is clinically characterized by joint pain, nighttime pain, functional impairment and limited movement [1, 2]
This assessment includes evaluating the efficacy of the current medication in managing glycemic levels or facilitating weight loss, as well as any side effects the patient may be experiencing
3 shows univariate regression analysis for GLP-1 secretory responses after oral glucose ingestion, from which responses appear to be predicted by baseline characteristics such as age, body weight (obesity), fasting NEFA concentrations and fasting glucagon concentrations